911132-35-9Relevant academic research and scientific papers
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A new class of agents with high apoptotic activity in chronic myelogenous leukemia K562 cells and in cells from patients at onset and who were imatinib-resistant
Silvestri, Romano,Marfè, Gabriella,Artico, Marino,La Regina, Giuseppe,Lavecchia, Antonio,Novellino, Ettore,Morgante, Manuela,Di Stefano, Carla,Catalano, Gianfranco,Filomeni, Giuseppe,Abruzzese, Elisabetta,Ciriolo, Maria Rosa,Russo, Matteo Antonio,Amadori, Sergio,Cirilli, Roberto,La Torre, Francesco,Salimei, Paola Sinibaldi
, p. 5840 - 5844 (2006)
Pyrrolo[1,2-b][1,2,5]benzothiadiazepine 5,5-dioxides (PBTDs) induced apoptosis in human BCR-ABL-expressing leukemia cells. The apoptotic activity was also observed in primary leukemic blasts, obtained from chronic myelogenous leukemia (CML) patients at on
Benzodiazepine Derivatives and Uses Thereof on Medical Field
-
Page/Page column 6-7, (2008/12/08)
The invention concerns benzodiazepine derivatives of formula wherein Y it is SO2 or NR, wherein R is H or C1-C6 alkyl; X is H, C1-C12 alkyl, —CO, —SO, —SO2, or —CO—R2, SO—R2
